Guidelines for the Diagnosis of Antibody-Mediated Rejection in Pancreas Allografts—Updated Banff Grading Schema
2011 · American Journal of Transplantation · 131 citations
https://doi.org/10.1111/j.1600-6143.2011.03670.x
É
Érika Bevilaqua Rangel
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
188
Papers
2.7K
Citations
23
h-index
51
i10-index
Érika Bevilaqua Rangel is an academic researcher from Hospital Israelita Albert Einstein. The author has contributed to research in topics: Renal Transplantation Outcomes and Treatments & Organ Transplantation Techniques and Outcomes & Healthcare during COVID-19 Pandemic. The author has an h-index of 23, co-authored 160 publications.
ORCID: 0000-0003-0982-2484Papers by this author
worksKidney-derived c-kit+ progenitor/stem cells contribute to podocyte recovery in a model of acute proteinuria
2018 · Scientific Reports · 24 citations
https://doi.org/10.1038/s41598-018-33082-x
The evolution of diabetic chronic complications after pancreas transplantation
2009 · Diabetology & Metabolic Syndrome · 5 citations
https://doi.org/10.1186/1758-5996-1-11
Simultaneous pancreas-kidney transplantation and the impact of postoperative complications on hospitalization cost.
2021 · Figshare · 4 citations
https://doi.org/10.6084/m9.figshare.14317000
Need for dental treatment in patients on the waiting list for liver and simultaneous pancreas-kidney transplant at a single center.
2019 · Figshare · 4 citations
https://doi.org/10.6084/m9.figshare.10025639
Combining sodium-glucose co-transporter-2 inhibitor with mesenchymal stem cells and brown adipose tissue (BAT) and white adipose tissue (WAT) transplantation to mitigate the progression of diabetic kidney disease: a pre-clinical approach
2025 · Stem Cell Research & Therapy · 1 citations
https://doi.org/10.1186/s13287-025-04358-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat